Gold prices rise from 2-wk low with focus on Russia-Ukraine, Jackson Hole
SAN DIEGO - Tang Capital Management, LLC disclosed on April 24, 2025, that it holds a 1.2% interest in Mural Oncology Plc, equivalent to 212,551 shares, according to a regulatory filing with the Irish Takeover Panel. The investment firm, which operates Tang Capital Partners (WA:CPAP), LP and Tang Capital Partners International, LP, reported its position following recent transactions in Mural Oncology’s securities.
The disclosure comes amid Mural Oncology’s status as a potential takeover target, although Tang Capital has stated that it is not making disclosures in respect of any other party to the offer at this time. The recent sales of shares by Tang Capital occurred on April 23, 2025, with transactions ranging from $2.75 to $2.77 per unit.
No cash-settled or stock-settled derivative positions were reported, and the firm indicated that there were no indemnity or option arrangements, or any agreements or understandings, that might serve as an inducement to deal or refrain from dealing in the relevant securities.
The announcement from Tang Capital Management, LLC, helmed by Chief Financial Officer Michael Hearne, was made in accordance with Rule 8.3 of the Irish Takeover Panel Act, 1997, Takeover Rules, 2022. Such disclosures are mandated for persons with interests in relevant securities representing 1% or more of the share capital of a company involved in a takeover situation.
This report is based on a press release statement and provides a factual account of Tang Capital’s disclosed interest in Mural Oncology Plc without any additional commentary or speculation on the potential implications of this stake for the market or the ongoing takeover situation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.